Kursprognose für Bluejay Diagnostics Inc (BJDX)BJDXBluejay Diagnostics Inc

Alphio's BJDX stock price prediction model matches the current Bluejay Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.33 (-0.86%). The 1-week path is $2.39 (+1.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Bluejay Diagnostics Inc (BJDX) appears to be a good buy right now. The current price is $2.35, which is significantly lower than its 52-week high of $28.00, indicating potential for recovery. The company recently reported a 7.31% increase in stock price following its latest earnings announcement, suggesting positive market sentiment. Additionally, the RSI is at 51.095, indicating the stock is neither overbought nor oversold, which is favorable for entry. However, the company has a high net loss of $2,324,013 in Q2 2026, which poses a risk to investors. Overall, the combination of recent strategic partnerships and potential market expansion makes BJDX a compelling investment opportunity despite the risks.

Bluejay Diagnostics Inc (BJDX) last closed at $2.3499999, gaining +7.31%. These facts feed the 1-day and 1-week BJDX price prediction above.